2.58
Spero Therapeutics Inc Azioni (SPRO) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
61.65%
5.442
|
14.19 | 5.874 | 15.04 | 13.47 |
|
|
19.69%
13.36
|
16.63 | 20.61 | 36.77 | 32.06 |
| Benefits Costs and Expenses |
19.29%
12.82
|
15.89 | 19.74 | 116.54 | - |
| Costs And Expenses |
19.29%
12.82
|
15.89 | 19.74 | 31.97 | 32.06 |
| Operating Income/Loss |
223.90%
-7.916
|
-2.444 | -14.73 | -21.73 | -18.59 |
| Nonoperating Income/Loss |
28.23%
0.534
|
0.744 | 0.865 | 1.127 | 1.156 |
| Income/Loss From Continuing Operations Before Tax |
334.24%
-7.382
|
-1.70 | -13.87 | -101.50 | 13.47 |
| Income Tax Expense/Benefit |
-
|
- | - | 0.29 | -0.29 |
| Income/Loss From Continuing Operations After Tax |
334.24%
-7.382
|
-1.70 | -13.87 | -20.89 | -17.15 |
|
|
334.24%
-7.382
|
-1.70 | -13.87 | -20.89 | -17.15 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.45%
56.28
|
56.03 | 55.38 | 0.1681 | 54.12 |
| Diluted Average Shares |
0.45%
56.28
|
56.03 | 55.38 | 0.1681 | 54.12 |
| Basic Earnings Per Share |
333.33%
-0.13
|
-0.03 | -0.25 | -0.38 | -0.32 |
| Diluted Earnings Per Share |
333.33%
-0.13
|
-0.03 | -0.25 | -0.38 | -0.32 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):